Veli Topkara is a Cardiology physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 545 publications with 9,278 citations (h-index 49).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 Highland Ave
Madison, WI 537923720
Telephone
608-263-1690Provider last certified this registry record 10 Dec 2024.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20242 payments
- Abbott LaboratoriesProgram year20232 payments
- Novartis Pharmaceuticals CorporationProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.6%Beta blocker28.3%Metoprolol Succinate57%Carvedilol43%Part D<11 patientsAldosterone antagonist (MRA)21.7%Spironolactone100%Part D≥15 patients+ 2 more classes in this area
Metabolism & gastrointestinal
27.4%SGLT2 inhibitor27.4%Jardiance55%Farxiga45%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Role of RNA helicase Ddx5 in pathological cardiac remodeling
University of Wisconsin-Madison
FY2026$517,422R01HL170132 - Role of RNA helicase Ddx5 in pathological cardiac remodeling
University of Wisconsin-Madison
FY2025$527,982R01HL170132 - Role of RNA helicase Ddx5 in pathological cardiac remodeling
University of Wisconsin-Madison
FY2024$517,422R01HL170132
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Albertini, MD
University of Wisconsin–Madison
Bryn Webb, MD
University of Wisconsin–Madison
Jeannina Smith, MD
University of Wisconsin–Madison
Carolina Pusec, PhD, MD
University of Wisconsin–Madison
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”